Zobrazeno 1 - 10
of 83
pro vyhledávání: '"G. Trespi"'
Autor:
Almalina Bacigalupo, G. Trespi, M. T. Van Lint, Stefania Bregante, Nicola Mordini, G. Berisso, S Bertilson, A M Raiola, Francesca Gualandi, Elisabetta Tedone, Teresa Lamparelli, Federica Benvenuto, O. Figari
Publikováno v:
Bone Marrow Transplantation. 26:23-29
This is a dose-finding study using foscarnet for CMV prophylaxis after allogeneic bone marrow transplantation (BMT) in 20 high risk patients (unrelated donors, or T cell depleted, and/or advanced disease). Foscarnet was started on day +1 after BMT an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec22a9b633f8f2bbfe5309924feb84e7
https://doi.org/10.1038/sj.bmt.1702450
https://doi.org/10.1038/sj.bmt.1702450
Publikováno v:
European journal of clinical pharmacology. 52(5)
Objective: To compare the pharmacokinetics of foscarnet administered as an infusion twice daily (BID) or thrice daily (TID), and to compare the effects on the electrolyte balance, cardiac and renal functions over a 3-week induction treatment of Cytom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13c5393a371251480423a1fca3202c9b
https://pubmed.ncbi.nlm.nih.gov/9272411
https://pubmed.ncbi.nlm.nih.gov/9272411
Autor:
A, Bacigalupo, S, Bregante, E, Tedone, A, Isaza, M T, Van Lint, F, Moro, G, Trespi, D, Occhini, F, Gualandi, T, Lamparelli, A M, Marmont
Publikováno v:
Bone marrow transplantation. 18
Thirty two allogeneic bone marrow transplant (BMT) recipients, aged 16-55 (median 35), with CMV antigenemia (=5 positive cells) developing at a median interval from BMT of 49 days, were given combined treatment with foscarnet and ganciclovir for 15 d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0a118d722c1c353563f23387e29ad57e
https://pubmed.ncbi.nlm.nih.gov/8932810
https://pubmed.ncbi.nlm.nih.gov/8932810
Autor:
A, Bacigalupo, S, Bregante, E, Tedone, A, Isaza, M T, Van Lint, G, Trespi, D, Occhini, F, Gualandi, T, Lamparelli, A M, Marmont
Publikováno v:
Transplantation. 62(3)
In a previous study, we showed that patients undergoing allogeneic hemopoietic stem cell transplantation (HSCT) who had cytomegalovirus (CMV) antigenemia with more than 4 CMV antigen-positive cells/200,000 have a high transplant-related mortality (TR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cb628d0fa878cf5d23510b726e5d944f
https://pubmed.ncbi.nlm.nih.gov/8779686
https://pubmed.ncbi.nlm.nih.gov/8779686
Autor:
A, Bacigalupo, E, Tedone, M T, Van Lint, G, Trespi, M, Lonngren, M A, Sanna, F, Moro, F, Frassoni, D, Occhini, F, Gualandi
Publikováno v:
Bone marrow transplantation. 13(6)
Eleven patients underwent bone marrow transplant (BMT) from an HLA-identical sibling following single dose total body irradiation (TBI), with in vivo and ex vivo T cell depletion (TCD). In spite of CMV prophylaxis with acyclovir and high-dose i.v. Ig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::99d98cc17268ab24bf6505931be1aee5
https://pubmed.ncbi.nlm.nih.gov/7920315
https://pubmed.ncbi.nlm.nih.gov/7920315
Autor:
A, Bacigalupo, M T, van Lint, E, Tedone, F, Moro, M A, Sanna, M, Longren, G, Trespi, F, Frassoni, D, Occhini, F, Gualandi
Publikováno v:
Bone marrow transplantation. 13(6)
Twenty-five patients with hematologic malignancies (n = 21) or aplastic anemia (n = 4) undergoing an allogeneic BMT from an HLA-identical sibling developed cytomegalovirus (CMV) antigenemia at a mean interval from BMT of 41 days (range 16-141 days).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4f313a5e3e08269272a4baff15aa544d
https://pubmed.ncbi.nlm.nih.gov/7920310
https://pubmed.ncbi.nlm.nih.gov/7920310
Autor:
G, Barbarini, G, Pelissero, G, Trespi, W, Calderon, A, Maccabruni, D, Campisi, A, Chiesa, G, Filice
Publikováno v:
Bollettino dell'Istituto sieroterapico milanese. 68(1)
In this work we reported the results obtained using two ELISA-tests (the seropositivity was confirmed by Western-Blot) for detection of HIV-Ab in normal and at risk population (according by the classification from C.D.C. 1982) exposed to screening fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a8efd3e0fd206518d280758e33c6fdea
https://pubmed.ncbi.nlm.nih.gov/2491286
https://pubmed.ncbi.nlm.nih.gov/2491286
Publikováno v:
Bollettino dell'Istituto sieroterapico milanese. 65(5)
The authors have evaluated comparatively the diagnostic reliability of four RIA or ELISA tests for the determination of the anti-HBc IgM in serum. Statistically it has been possible to point out significant differences as regards the various Kits.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::18eb844eac28d8757c34fe6745a11c32
https://pubmed.ncbi.nlm.nih.gov/3828087
https://pubmed.ncbi.nlm.nih.gov/3828087
Publikováno v:
Microbiologica. 11(1)
A new cell line, obtained by co-cultivation of fetal lamb kidney cells and lymphocytes collected from an adult calf affected by enzootic bovine leukemia, was studied for bovine leukemia virus (BLV) morphogenesis. In this new cell line, called FLK-BLV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::995f99bf9368741a282dc60e0c734378
https://pubmed.ncbi.nlm.nih.gov/2832708
https://pubmed.ncbi.nlm.nih.gov/2832708
Publikováno v:
Il Farmaco; edizione pratica. 39(8)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c17be14cebaa7c558f9a14887040cce5
https://pubmed.ncbi.nlm.nih.gov/6468645
https://pubmed.ncbi.nlm.nih.gov/6468645